Literature DB >> 10444484

Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells.

J W Gu1, A L Brady, V Anand, M C Moore, W C Kelly, T H Adair.   

Abstract

We tested whether adenosine has differential effects on vascular endothelial growth factor (VEGF) expression under normoxic and hypoxic conditions, and whether A(1) or A(2) receptors (A(1)R; A(2)R) mediate these effects. Myocardial vascular smooth muscle cells (MVSMCs) from dog coronary artery were exposed to hypoxia (1% O(2)) or normoxia (20% O(2)) in the absence and presence of adenosine agonists or antagonists for 18 h. VEGF protein levels were measured in media with ELISA. VEGF mRNA expression was determined with Northern blot analysis. Under normoxic conditions, the adenosine A(1)R agonists, N(6)-cyclopentyladenosine and R(-)-N(6)-(2-phenylisopropyl)adenosine did not increase VEGF protein levels at A(1)R stimulatory concentrations. However, adenosine (5 microM) and the adenosine A(2)R agonist N(6)-[2-(3, 5-dimethoxyphenyl)-2-(2-methylphenyl)]ethyl adenosine (DPMA; 100 nM) increased VEGF protein levels by 51 and 132% and increased VEGF mRNA expression by 44 and 90%, respectively, in cultured MVSMCs under normoxic conditions. Hypoxia caused an approximately fourfold increase in VEGF protein and mRNA expression, which could not be augmented with exogenous adenosine, A(2)R agonist (DPMA), or A(1)R agonist [1,3-diethyl-8-phenylxanthine (DPX)]. The A(2)R antagonist 8-(3-chlorostyryl)-caffeine completely blocked adenosine-induced VEGF protein and mRNA expression and decreased baseline VEGF protein levels by up to approximately 60% under normoxic conditions but only by approximately 25% under hypoxic conditions. The A(1)R antagonist DPX had no effect. These results are consistent with the hypothesis that 1) adenosine increases VEGF protein and mRNA expression by way of A(2)R. 2) Adenosine plays a major role as an autocrine factor regulating VEGF expression during normoxic conditions but has a relatively minor role during hypoxic conditions. 3) Endogenous adenosine can account for the majority of basal VEGF secretion by MVSMCs under normoxic conditions and could therefore be a maintenance factor for the vasculature.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444484     DOI: 10.1152/ajpheart.1999.277.2.H595

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

Review 1.  Adenosine receptors in wound healing, fibrosis and angiogenesis.

Authors:  Igor Feoktistov; Italo Biaggioni; Bruce N Cronstein
Journal:  Handb Exp Pharmacol       Date:  2009

2.  Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants.

Authors:  Eric M George; Kathy Cockrell; Thomas H Adair; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-20       Impact factor: 3.619

3.  CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.

Authors:  Jan Schulte Am Esch; Simon C Robson; Moritz Schmelzle; Constanze Duhme; Wolfgang Junger; Steven D Salhanick; Yu Chen; Yan Wu; Vasilis Toxavidis; Eva Csizmadia; Lihui Han; Shu Bian; Günter Fürst; Martina Nowak; Seth J Karp; Wolfram T Knoefel
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

4.  Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.

Authors:  Samuel Joseph Leibovich; Jiang-Fan Chen; Grace Pinhal-Enfield; Paula C Belem; Genie Elson; Anthony Rosania; Madhuri Ramanathan; Carmen Montesinos; Marlene Jacobson; Michael A Schwarzschild; J Stephen Fink; Bruce Cronstein
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 5.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

6.  Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis.

Authors:  M Carmen Montesinos; Jason P Shaw; Herman Yee; Peter Shamamian; Bruce N Cronstein
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

7.  Proof-of-principle investigation of an algorithmic model of adenosine-mediated angiogenesis.

Authors:  Francisco Azuaje; Frédérique Léonard; Magali Rolland-Turner; Yvan Devaux; Daniel R Wagner
Journal:  Theor Biol Med Model       Date:  2011-04-08       Impact factor: 2.432

8.  Adenosine infusion increases plasma levels of VEGF in humans.

Authors:  Thomas H Adair; Reid Cotten; Jian-Wei Gu; Janelle S Pryor; Kenneth R Bennett; Michael R McMullan; Preston McDonnell; Jean-Pierre Montani
Journal:  BMC Physiol       Date:  2005-06-20

9.  Caffeine-induced endothelial cell death and the inhibition of angiogenesis.

Authors:  Hua Li; Sheng-Yu Jin; Hyun-Joon Son; Je Hoon Seo; Goo-Bo Jeong
Journal:  Anat Cell Biol       Date:  2013-03-25

10.  Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1.

Authors:  Srikanth Koneru; Suresh Varma Penumathsa; Mahesh Thirunavukkarasu; Ramesh Vidavalur; Lijun Zhan; Pawan K Singal; Richard M Engelman; Dipak K Das; Nilanjana Maulik
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.